Kerman Ilan A, Glover Matthew E, Lin Yezhe, West Jennifer L, Hanlon Alexandra L, Kablinger Anita S, Clinton Sarah M
Mental Health Integrated Care Community, Minneapolis Veterans Administration Health Care System, Minneapolis, MN, United States.
School of Neuroscience, Virginia Tech, Blacksburg, VA, United States.
Front Pharmacol. 2024 Jan 8;14:1290052. doi: 10.3389/fphar.2023.1290052. eCollection 2023.
This study sought to investigate the relationship between antibiotic exposure and subsequent risk of psychiatric disorders. This retrospective cohort study used a national database of 69 million patients from 54 large healthcare organizations. We identified a cohort of 20,214 (42.5% male; 57.9 ± 15.1 years old [mean ± SD]) adults without prior neuropsychiatric diagnoses who received antibiotics during hospitalization. Matched controls included 41,555 (39.6% male; 57.3 ± 15.5 years old) hospitalized adults without antibiotic exposure. The two cohorts were balanced for potential confounders, including demographics and variables with potential to affect: the microbiome, mental health, medical comorbidity, and overall health status. Data were stratified by age and by sex, and outcome measures were assessed starting 6 months after hospital discharge. Antibiotic exposure was consistently associated with a significant decrease in the risk of novel mood disorders and anxiety and stressor-related disorders in: men (mood (OR 0.84, 95% CI 0.77, 0.91), anxiety (OR 0.88, 95% CI 0.82, 0.95), women (mood (OR 0.94, 95% CI 0.89,1.00), anxiety (OR 0.93, 95% CI 0.88, 0.98), those who are 26-49 years old (mood (OR 0.87, 95% CI 0.80, 0.94), anxiety (OR 0.90, 95% CI 0.84, 0.97)), and in those ≥50 years old (mood (OR 0.91, 95% CI 0.86, 0.97), anxiety (OR 0.92, 95% CI 0.87, 0.97). Risk of intentional harm and suicidality was decreased in men (OR 0.73, 95% CI 0.55, 0.98) and in those ≥50 years old (OR 0.67, 95% CI 0.49, 0.92). Risk of psychotic disorders was also decreased in subjects ≥50 years old (OR 0.83, 95 CI: 0.69, 0.99). Use of antibiotics in the inpatient setting is associated with protective effects against multiple psychiatric outcomes in an age- and sex-dependent manner.
本研究旨在调查抗生素暴露与随后发生精神障碍风险之间的关系。这项回顾性队列研究使用了来自54个大型医疗保健机构的6900万患者的全国性数据库。我们确定了一组20214名(42.5%为男性;平均年龄57.9±15.1岁[均值±标准差])在住院期间接受过抗生素治疗且无既往神经精神疾病诊断的成年人。匹配的对照组包括41555名(39.6%为男性;平均年龄57.3±15.5岁)未接触抗生素的住院成年人。这两组在潜在混杂因素方面保持平衡,这些因素包括人口统计学因素以及可能影响微生物群、心理健康、合并症和整体健康状况的变量。数据按年龄和性别分层,并从出院后6个月开始评估结局指标。抗生素暴露与新发情绪障碍、焦虑和应激源相关障碍风险的显著降低始终相关,在男性中(情绪障碍(比值比[OR]0.84,95%置信区间[CI]0.77,0.91),焦虑障碍(OR 0.88,95%CI 0.82,0.95)),女性中(情绪障碍(OR 0.94,95%CI 0.89,1.00),焦虑障碍(OR 0.93,95%CI 0.88,0.98)),26 - 49岁人群中(情绪障碍(OR 0.87,95%CI 0.80,0.94),焦虑障碍(OR 0.90,95%CI 0.84,0.97)),以及50岁及以上人群中(情绪障碍(OR 0.91,95%CI 0.86,0.97),焦虑障碍(OR 0.92,95%CI 0.87,0.97))。男性(OR 0.73,95%CI 0.55,0.98)以及50岁及以上人群(OR 0.67,95%CI 0.49,0.92)的故意伤害和自杀风险降低。50岁及以上人群的精神分裂症风险也降低(OR 0.83,95%CI:0.69,0.99)。住院环境中抗生素的使用以年龄和性别依赖的方式对多种精神疾病结局具有保护作用。